Table 4.
Target prediction and pathway enrichment analysis of hsa-miR-320a.
| Gene Symbol | Gene Description | miRANDA | miRDB | TargetScan |
|---|---|---|---|---|
| BMPR1A | bone morphogenetic protein receptor, type IA | −1.99 | 86 | −0.4 |
| CDK13 | cyclin-dependent kinase 13 | −1.69 | 95 | −0.46 |
| DNER | delta/notch-like EGF repeat containing | −2.23 | 98 | −0.51 |
| MLLT3 | myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 | −2.28 | 98 | −0.48 |
| PBX3 | pre-B-cell leukemia homeobox 3 | −2.47 | 100 | −0.49 |
| SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A | −1.95 | 99 | −0.39 |
In silico analysis predicted 6 target mRNAs for hsa-miR-320a.